Boston Scientific Embol-X Buy Readies Firm For Carotid Stent Race

Boston Scientific's acquisition of embolic protection technology developed by Embol-X may help level the playing field with competitors Guidant and Johnson & Johnson in the race to bring carotid stent technology to market.

More from Archive

More from Medtech Insight